Auditory sensory gating, hippocampal volume, and catecholamine metabolism in schizophrenics and their siblings. 1994

M C Waldo, and E Cawthra, and L E Adler, and S Dubester, and M Staunton, and H Nagamoto, and N Baker, and A Madison, and J Simon, and A Scherzinger
Department of Psychiatry, Denver VA Medical Center, CO 80262.

Schizophrenia may result from the concerted action of several pathophysiological factors. This pilot study compared the distribution of measurements of three such putative factors in 11 schizophrenics and their siblings: a neurophysiological deficit in auditory sensory gating, diminished hippocampal volume, and increased catecholamine metabolism. Abnormal auditory sensory gating was found in all schizophrenics in the 11 families studied and in 8 of their 20 siblings. Compared with the schizophrenics, the clinically unaffected siblings with abnormal auditory gating had larger hippocampal volume. There was no similar difference for the siblings with normal gating. The siblings with abnormal auditory gating also had lower homovanillic acid levels than the other siblings. The data suggest that a familial neuronal deficit, identified by diminished sensory gating, may be a necessary, but not sufficient factor in the pathogenesis of schizophrenia. Individuals with this deficit are generally clinically unaffected, except for schizophrenics, who also have other abnormalities, such as diminished hippocampal volume and increased catecholamine metabolism.

UI MeSH Term Description Entries
D008279 Magnetic Resonance Imaging Non-invasive method of demonstrating internal anatomy based on the principle that atomic nuclei in a strong magnetic field absorb pulses of radiofrequency energy and emit them as radiowaves which can be reconstructed into computerized images. The concept includes proton spin tomographic techniques. Chemical Shift Imaging,MR Tomography,MRI Scans,MRI, Functional,Magnetic Resonance Image,Magnetic Resonance Imaging, Functional,Magnetization Transfer Contrast Imaging,NMR Imaging,NMR Tomography,Tomography, NMR,Tomography, Proton Spin,fMRI,Functional Magnetic Resonance Imaging,Imaging, Chemical Shift,Proton Spin Tomography,Spin Echo Imaging,Steady-State Free Precession MRI,Tomography, MR,Zeugmatography,Chemical Shift Imagings,Echo Imaging, Spin,Echo Imagings, Spin,Functional MRI,Functional MRIs,Image, Magnetic Resonance,Imaging, Magnetic Resonance,Imaging, NMR,Imaging, Spin Echo,Imagings, Chemical Shift,Imagings, Spin Echo,MRI Scan,MRIs, Functional,Magnetic Resonance Images,Resonance Image, Magnetic,Scan, MRI,Scans, MRI,Shift Imaging, Chemical,Shift Imagings, Chemical,Spin Echo Imagings,Steady State Free Precession MRI
D008297 Male Males
D008734 Methoxyhydroxyphenylglycol Synthesized from endogenous epinephrine and norepinephrine in vivo. It is found in brain, blood, CSF, and urine, where its concentrations are used to measure catecholamine turnover. Hydroxymethoxyphenylglycol,MHPG,MOPEG,Vanylglycol,4-Hydroxy-3-methoxyphenylethylene Glycol,4-Hydroxy-3-methoxyphenylethyleneglycol,4-Hydroxy-3-methoxyphenylglycol,Methoxyhydroxyphenylglycol, (+)-Isomer,Methoxyhydroxyphenylglycol, (+-)-Isomer,Methoxyhydroxyphenylglycol, (-)-Isomer,4 Hydroxy 3 methoxyphenylethylene Glycol,4 Hydroxy 3 methoxyphenylethyleneglycol,4 Hydroxy 3 methoxyphenylglycol
D009433 Neural Inhibition The function of opposing or restraining the excitation of neurons or their target excitable cells. Inhibition, Neural
D011569 Psychiatric Status Rating Scales Standardized procedures utilizing rating scales or interview schedules carried out by health personnel for evaluating the degree of mental illness. Factor Construct Rating Scales (FCRS),Katz Adjustment Scales,Lorr's Inpatient Multidimensional Psychiatric Rating Scale,Wittenborn Scales,Edinburgh Postnatal Depression Scale,Mini International Neuropsychiatric Interview
D002395 Catecholamines A general class of ortho-dihydroxyphenylalkylamines derived from TYROSINE. Catecholamine,Sympathin,Sympathins
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D004298 Dopamine One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action. Hydroxytyramine,3,4-Dihydroxyphenethylamine,4-(2-Aminoethyl)-1,2-benzenediol,Dopamine Hydrochloride,Intropin,3,4 Dihydroxyphenethylamine,Hydrochloride, Dopamine
D005072 Evoked Potentials, Auditory The electric response evoked in the CEREBRAL CORTEX by ACOUSTIC STIMULATION or stimulation of the AUDITORY PATHWAYS. Auditory Evoked Potentials,Auditory Evoked Response,Auditory Evoked Potential,Auditory Evoked Responses,Evoked Potential, Auditory,Evoked Response, Auditory,Evoked Responses, Auditory,Potentials, Auditory Evoked
D005260 Female Females

Related Publications

M C Waldo, and E Cawthra, and L E Adler, and S Dubester, and M Staunton, and H Nagamoto, and N Baker, and A Madison, and J Simon, and A Scherzinger
October 1992, Psychiatry research,
M C Waldo, and E Cawthra, and L E Adler, and S Dubester, and M Staunton, and H Nagamoto, and N Baker, and A Madison, and J Simon, and A Scherzinger
January 1988, Schizophrenia research,
M C Waldo, and E Cawthra, and L E Adler, and S Dubester, and M Staunton, and H Nagamoto, and N Baker, and A Madison, and J Simon, and A Scherzinger
October 2007, Frontiers of medicine in China,
M C Waldo, and E Cawthra, and L E Adler, and S Dubester, and M Staunton, and H Nagamoto, and N Baker, and A Madison, and J Simon, and A Scherzinger
October 1992, Biological psychiatry,
M C Waldo, and E Cawthra, and L E Adler, and S Dubester, and M Staunton, and H Nagamoto, and N Baker, and A Madison, and J Simon, and A Scherzinger
December 1995, American journal of medical genetics,
M C Waldo, and E Cawthra, and L E Adler, and S Dubester, and M Staunton, and H Nagamoto, and N Baker, and A Madison, and J Simon, and A Scherzinger
January 1990, Biological psychiatry,
M C Waldo, and E Cawthra, and L E Adler, and S Dubester, and M Staunton, and H Nagamoto, and N Baker, and A Madison, and J Simon, and A Scherzinger
January 2009, Neuropsychobiology,
M C Waldo, and E Cawthra, and L E Adler, and S Dubester, and M Staunton, and H Nagamoto, and N Baker, and A Madison, and J Simon, and A Scherzinger
November 2008, Psychophysiology,
M C Waldo, and E Cawthra, and L E Adler, and S Dubester, and M Staunton, and H Nagamoto, and N Baker, and A Madison, and J Simon, and A Scherzinger
July 1998, Fortschritte der Neurologie-Psychiatrie,
M C Waldo, and E Cawthra, and L E Adler, and S Dubester, and M Staunton, and H Nagamoto, and N Baker, and A Madison, and J Simon, and A Scherzinger
August 2010, Zhonghua yi xue za zhi,
Copied contents to your clipboard!